The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...

BioNTech (BNTX) on Friday announced separate agreements with the US National Institutes of Health and the University of Pennsylvania to settle royalty claims related to sales of its COVID-19 ...

BioNTech SE has completed its acquisition of Biotheus, a clinical-stage biotechnology company focused on developing novel antibodies for cancer and inflammatory diseases. This acquisition ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

(RTTNews) - BioNTech SE (BNTX), an immunotherapy company, on Monday announced the completion of its acquisition of Biotheus, a clinical-stage biotechnology company focused on the development of ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the treatment of advanced cancers With the closing of the ...

Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job February 4, 2025 BioNTech has entered into two separate settlement agreements with the U.S. National Institutes ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T ...

Acquisition to strengthen key pillar of BioNTech's oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the treatment of advanced cancers With the closing of the ...